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ABSTRACT: Matrix metalloproteinase-3 (MMP-3)
deficiency in mice was previously reported to result in a
transiently retarded granule cell migration at postnatal
day 8 (P8) and a sustained disturbed arborization of Pur-
kinje cell dendrites from P8 on, concomitant with a
delayed synapse formation between granule cells and
Purkinje cells and resulting in mild deficits in motor per-
formance in adult animals. However, the molecular
mechanisms by which MMP-3 contributes to proper
development of the cerebellar cortex during the first
postnatal weeks remains unknown. In this study, we used
a functional proteomics approach to investigate altera-
tions in protein expression in postnatal cerebella of wild-
type versus MMP-3 deficient mice, and to further eluci-
date MMP-3-dependent pathways and downstream tar-
gets in vivo. At P8, two-dimensional difference gel
electrophoresis and mass spectrometry identified 20
unique proteins with a different expression between the
two genotypes. Subsequent “Ingenuity Pathway Analy-
sis” analysis and Western blotting indicate that the chap-
eronin containing T-complex polypeptide 1, subunit 6A
and the MAP kinase signaling pathway play a key role in
the MMP-3-dependent regulation of neurite outgrowth
and neuronal migration in the developing brain. VC 2015
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INTRODUCTION
The postnatal mouse cerebellum forms an ideal
model system to unravel and study the molecular
mechanisms of brain development, and more specifi-
cally of cellular processes such as proliferation, dif-
ferentiation, migration, neurite outgrowth, and
synaptogenesis. In rodents, the cerebellum develops
predominantly during the first 3 weeks after birth into
a well-characterized structure with a limited amount
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of cell types. Novel insights into these developmental
brain processes are highly required, not only for a
better understanding of normal brain wiring and func-
tioning, but also and importantly to support the
search for new treatments in case of brain injuries,
learning disabilities and age-related neurodegenera-
tive brain disorders.
Matrix metalloproteinases (MMPs) are increas-
ingly being recognized as important contributors to
central nervous system (CNS) development (Yong
et al., 2001; Vaillant et al., 2003; Ayoub et al., 2005;
Larsen et al., 2006; Verslegers et al., 2013). Their
field of action is, in contrast to their nomenclature,
not restricted to proteolysis of extracellular matrix
proteins, but also comprises the (in)activation of a
broad range of signaling molecules, such as recep-
tors, adhesion molecules, chemokines, cytokines, and
even intracellular and intranuclear substrates (Cauwe
et al., 2009; Morrison et al., 2009; Cauwe and Opde-
nakker, 2010). Over the past decennia, uncontrolled
or unbalanced MMP activities in CNS diseases have
received far more attention than their supporting role
in physiological processes in the developing and
adult CNS (Rosenberg, 1995, 2002; Rivera et al.,
2010; Kim and Hwang, 2011). Stromelysin-1 or
MMP-3 is especially known for its large degradome,
mainly obtained from in vitro studies, and has been
associated with several CNS disorders/injuries, for
example, multiple sclerosis, glioma, stroke, Alzhei-
mer and Parkinson’s disease (Kim and Hwang,
2011). Besides, studies pointing towards its potential
as a modulator of fundamental CNS physiological
processes are emerging (Van Hove et al., 2012). As
such, we recently reported that MMP-3 deficient
(MMP-32/2) mice show an aberrant morphogenesis
of the cerebellar cortex during the first postnatal
weeks (Van Hove et al., 2012). More specifically,
MMP-3 deficiency resulted in a delayed migration of
the granule cells and GABAergic interneurons, as
well as a long-lasting aberrant dendritic arborization
of the Purkinje cells from postnatal day 8 (P8) on.
Concomitant with a transiently disturbed synaptogen-
esis on these Purkinje cells, mild but sustained motor
deficits could be demonstrated in adult MMP-32/2
mice, as compared to wild-type (WT) littermates. To
understand the mechanisms underlying the contribu-
tion of MMP-3 to development of the cerebellum, or
the brain in general, and to provide valuable insights
into (possibly new) downstream targets of MMP-3, a
two dimensional fluorescence difference gel electro-
phoresis (2-D DIGE) approach was applied to P8 cer-
ebella of WT and MMP-32/2 mice. Twenty
differential proteins were discovered after mass spec-
trometry analysis, and validation by Western blotting
confirmed a link between T-complex protein 1 subu-
nit zeta (CCT6a), the phosphorylation status of
mitogen-activated protein kinase (MAPK, ERK1/
ERK2) and the previously described cellular pheno-
type in MMP-32/2 mice.
MATERIALS AND METHODS
Animals
MMP-3 deficient (MMP-32/2) and wild-type (WT) litter-
mates from heterozygous breeding pairs (50% Bl6 3 25%
B10 3 25% RIII) (Mudgett, Merck labs) were used for all
experiments. All animals were housed under standard labo-
ratory conditions in a 11/13h light-dark cycle with food and
water ad libitum. Genotyping was performed on tail DNA
with previously described primers (Van Hove et al., 2012).
All animal experiments were approved by the Institutional
Ethical Committee of KU Leuven and are in strict accord-
ance with the European Communities Council Directive of
22 September 2010 (2010/63/EU).
Fluorescent Two-Dimensional Difference
Gel Electrophoresis
Cerebella of MMP-32/2 (n5 5) and WT mice (n5 5) were
dissected at postnatal day 8 (P8), immediately frozen into
ice-cold (240C a 250C) isopropanol and stored at
280C. To homogenize the samples, every single cerebel-
lum was mixed with lysis buffer (7 M Urea, 2 M Thiourea,
4% CHAPS, 40 mM Tris base, 1% Dithiothreitol (DTT)),
supplemented with Complete Protease Inhibitor (Roche
Diagnostics, Switzerland), shortly centrifuged at
13,000 rpm and sonicated for 3 3 25 s. After a 1 h incuba-
tion at room temperature, homogenates were briefly soni-
cated and centrifuged at 13,000 rpm for 20 min at 4C.
Subsequently, the supernatant was dialyzed against milli-Q
(Millipore) water for 2 h to remove residual salts, using a
membrane with 500 Da cutoff (Spectra/Por, Biotech, Omni-
labo). Protein concentrations were measured using the
Qubit Protein Assay Kit (Invitrogen), according to the man-
ufacturer’s instructions.
The 2-D DIGE technology relies on the differential
labeling of proteins with fluorescent cyanine dyes and
allows for sample multiplexing and low variations. There-
fore, fifty mg of each sample was labeled with the fluores-
cent cyanine dyes Cy3 or Cy5 and kept on ice in darkness
for 30 min. An internal standard was included to normalize
across the different gels, which consists of equal amounts
of every protein sample, and of which 50 mg was labeled
with Cy2. One ml of 10 mM lysine was added to the sam-
ples to block the labeling reaction. After 15 min on ice in
darkness, the Cy2-, Cy3-, and Cy5-labeled fractions were
mixed together and an equal volume of lysis buffer was
added. The first dimension is an isoelectric focusing, which
was executed on an Ettan IPGphor Cup Loading Manifold
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system according to the manufacturer’s instructions. After
the run, proteins on the strip (Immobiline Drystrips, pH 3–
11) were equilibrated for 15 min in equilibration buffer (6 M
urea, 34.5% (v/v) glycerol and 10% w/v SDS in 1.5 M Tris-
HCl pH 8.8), supplemented with 1% (w/v) DTT and subse-
quently alkylated for 15 min in equilibration buffer, supple-
mented with 4.5% (w/v) iodoacetamide (Sigma-Aldrich).
After a brief immersion of the pH strips in 2X SDS running
buffer (10X running buffer: 250 mM Tris, 1.92 M glycine,
1% SDS, strips were loaded onto 12.5% polyacrylamide gels.
SDS-PAGE was conducted in the Ettan Dalt System (GE
Healthcare), first at 30 mA for 30 min and subsequently at 15
mA/gel overnight at 13C to separate the proteins in the sec-
ond dimension. Gels were imaged with the Ettan DIGE
Imager 1.0 (GE Healthcare). The acquired gel image triplets
(Cy2, Cy3, and Cy5) were analyzed with DeCyder 2D soft-
ware (GE Healthcare). The biological variation analysis
(BVA) module enables one to manually check matched spots
upon automatic spot detection and matching by the DeCyder
Batch processor. An independent Student’s t-test was applied
to identify the differential spots (p< 0.05) between MMP-
32/2 and WT cerebella.
Protein Identification
To identify the differential proteins, two-dimensional prep-
arative gels were run in a similar way as described above,
using 1 mg of the pooled samples. Afterwards, gels were
stained with Lava Purple (Gelcompany), spots of interest
were automatically excised from the gels (Ettan Spot
Picker, GE Healthcare), digested and spotted using a fully
automated Ettan Dalt Spot Handling Workstation. In col-
laboration with the Centre de Recherche Public-Gabriel
Lippmann in Luxemburg, MS and MS/MS spectra were
acquired using a 5800 MALDI TOF-TOF (Absciex, Sunny-
vale, CA), calibrated using the 4,700 peptide mass calibra-
tion kit (Applied Biosystems). Proteins were identified by
searching against the NCBI database, limited to the taxon-
omy of Rodents (downloaded 2012.06.04, 316675 sequen-
ces), using an in-house MASCOT server (version 2.3.0
Matrix Science, www.matrixscience.com, London, U.K.).
Searches were carried out defining trypsin as cleavage
agent and allowing for 2 missed cleavages. A mass window
of 100 ppm was tolerated for the precursor mass and 0.75
Da for fragment ion masses. The search meters allowed for
carboxymethylation of cysteine as fixed modification and
oxidation of methionine and of tryptophan (double oxida-
tion, and kynurenin formation) as variable modifications.
Proteins were considered identified when two, nonoverlap-
ping, individual peptides surpassed the peptide score
threshold. When this criterion was not met, additional pre-
cursors were selected and searched using the above-
described parameters. N-terminal acetylation was found by
changing the cleavage to semitryptic and adding N-
terminal acetyl as variable modification.
Finally, the web-based functional analysis tool
“Ingenuity Pathway Analysis” (IPA) was applied to iden-
tify the most relevant molecular networks, biological func-
tions and canonical pathways for the differential proteins.
The Benjamini-Hochberg multiple testing comparison
method was used and a p-value of 0.05 was considered stat-
istically significant.
Western Blotting
To confirm and validate the obtained 2-D DIGE data, West-
ern blotting was carried out on a selection of biologically rel-
evant and interesting proteins. P8 cerebella from both
genotypes (WT and MMP-32/2 mice, n5 at least 5) were
isolated, frozen in liquid nitrogen and homogenized in 2-D
DIGE lysis buffer. Additional samples homogenized in the
following lysisbuffer (50 mM Tris-HCl pH 8, 300 mM NaCl,
0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, pH 8
and 0.1% SDS), supplemented with 1 Complete, EDTA-free,
Mini Protease Inhibitor Cocktail Tablet (Davis and Laroche)
per 10 ml lysis buffer) were also used for the detection of
CCT subunits. Afterwards, cerebellar samples were sonicated
for 1 min, heated for 5 min at 70C and centrifuged at 16,000
g for 15 min. Protein concentrations were determined by the
method of Bradford using the Bio-Rad assay, measured with
a spectrophotometer (Thermo Scientific) at 595 nm and
related to a standard curve from known bovine serum albu-
min protein concentrations. Additional cerebellar extracts,
previously applied in the 2-D DIGE experiments, were used
for Western Blotting as well. Proteins were separated on 4–
12% NuPageVR Bis-Tris gels (Invitrogen) and transferred
using the fast iBlotVR Dry Blotting System (Invitrogen) onto
polyvinylidene difluoride or nitrocellulose membranes. Blots
were blocked for 2 h with 5% nonfat dry milk and incubated
overnight at 4C with antibodies against p44/42 MAPK (1/
500, 4695, Cell Signaling), Phospho-p44/42 mitogen-
activated protein kinase (pMAPK) (1/1000, 4370, Cell Sig-
naling) and members of the chaperonin containing TCP-1
complex (CCT), being CCT6a (1/500, sc-13896, Santa Cruz
Biotechnology) and the Carden lab antibodies CCT3, CCT4,
CCT6a, CCT6b (all 1/100), CCT5 (1/1000), and CCT7 (1/
200), which were produced as described (Roobol and Carden,
1999), to peptides from the C-termini of mouse subunit
sequences. After washing, the membranes were incubated
with the appropriate secondary horseradish peroxidase
(HRP)-conjugated secondary antibodies for 1 h. The Chemi-
Doc MP Imager (Bio-Rad) was used to visualize protein
bands via chemiluminescence detection (Supersignal West
Dura Extended Duration Substrate, Thermo Scientific) and to
measure optical densities of the protein bands and the Coo-
massie stain, which was used as protein loading control.
Western blot analyses were performed in duplo or triplo on
cerebellar extracts from at least five mice per genotype. Sta-
tistical analysis was performed using a Student’s t-test and a
p-value of 0.05 was considered statistically significant.
Immunohistochemistry
P8 WT mouse pups were deeply anesthetized and intracar-
dially perfused with 4% phosphate buffered paraformalde-
hyde. To determine regional and cellular expression, single
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and double immunofluorescent stainings were performed
on 10 mm sagittal cryosections, using Alexa Fluor second-
ary antibodies (Invitrogen) or the TSATM FT System (Per-
kinElmer) in combination with the following primary
antibodies: mouse anti-Calbindin-D-28K (1/1000, C9848,
Sigma-Aldrich), rabbit anti-p44/42 MAPK (1/250, 4695,
Cell Signaling) and rabbit anti-CCT6a (1/250, Carden lab),
all as previously published (Van Hove et al., 2012; Ver-
slegers et al., 2014). Stained sections were examined and
photographed using an Olympus FV1000 confocal
microscope.
RESULTS
Comparative Analysis of the Cerebellar
Proteome in P8 MMP-32/2 and WT Mice
The molecular impact of MMP-3 deficiency, previ-
ously shown to be a crucial protease for proper post-
natal cerebellar development and neurite formation
in the mouse (Van Hove et al., 2012), was investi-
gated by a 2-D DIGE screen of cerebella from WT
and MMP-32/2 pups at P8, the time point at which
the first clear morphological differences were
detected. The average ratio of the spot intensities
from protein samples of P8 MMP-32/2 and WT cere-
bella, randomly labeled with Cy3 or Cy5, was statisti-
cally analysed. Eighteen spots were considered
significantly different when using a p-value of 0.05
as cutoff (Fig. F11). Subsequent MALDI TOF/TOF
analysis of the 18 spots identified 20 unique proteins,
all listed in Table T11. Of note, six of the spots con-
tained two proteins and 6 of the identified proteins
were found in more than 1 spot, suggesting the pres-
ence of posttranslational modifications (PTMs) or
different protein isoforms. The range in which the
fluorescence levels differed between the two geno-
types varied from 14% to 219%. Eight of the 18 spots
displayed an upregulated expression in MMP-32/2
cerebella as compared to WT brain (Fig. F22).
To gain more insight into the biological functions
and potential interactions of these 20 proteins, IPA
analysis was applied. In the first subclass “molecular
and cellular functions,” proteins involved in cell
Figure 1 2-D DIGE gel images. (A) A representative grayscale 2-D DIGE overview image of the
internal standard mouse cerebellar lysates separated on a pH 3–11 (non-linear) 2-D gel. The 18 pro-
tein spots that showed statistically significant differences in fluorescence levels (p< 0.05) after
DeCyder analysis and that were identified, are numbered on this 2-D DIGE gel. (B) Selection of the
2-D gel view showing two of the differentially expressed spots containing CCT6a, more specifi-
cally spot 6 and 16, in WT or MMP-32/2 cerebella.
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morphology (p: 1.17 3 1023 – 3.56 3 1022), cell-to-
cell signaling and interaction (p: 1.17 3 10232 4.57
3 1022), and cellular assembly and organization (p:
1.17 3 10232 4.90 3 1022), were listed within the
“top bio functions” and considered as relevant for the
observed cerebellar phenotype in MMP-32/2 mice.
In the second subclass “physiological system devel-
opment and function,” IPA analysis revealed a signif-
icant enrichment for genes involved in nervous
system development and function (p: 1.17 3 1023 –
4.45 3 1022), in which most of the differential pro-
teins were associated with neuritogenesis. Further-
more, IPA analysis considered semaphorin signaling
in neurons (p: 3.51 3 1027) as the most significant
“top canonical pathway.” Finally, as most proteins do
not act as single entities but work together in net-
works, IPA also unveiled 2 “top molecular networks”
that represent associative network functions. The first
ranked top network, in which 12 of the 20 identified
proteins were involved, is “cell-to-cell signaling and
interaction.” A selection of this network is shown in
Figure F33. Interestingly, the second top network is
related to “cellular development,” substantiating a
role for MMP-3-related processes in cerebellar
development.
Confirmation and Validation of Putative
MMP-3 Downstream Targets by Western
Blot Analysis
For confirmative purposes, Western blotting was per-
formed for the molecular chaperone T-complex pro-
tein 1 subunit 6a (zeta 1) (CCT6a or TCP-1f) [Fig.
Table 1 List of proteins identified by mass spectrometry that show significant changes in expression between MMP-
32/2 and WT postnatal cerebella, classified according to the 2/2/WT ratio







16 T-complex protein 1 subunit zeta CCT6a 6753324 3.19 0.00003 240
10 Put. beta-actin ACTB 49868 1.40 0.032 269
Phosphoglycerate kinase PGK1 202423 1.40 0.032 182
17 Glyoxalase I GLO1 165932331 1.27 0.016 90
11 Cyclophilin-40 PPID 13385854 1.21 0.045 253
26S protease regulatory subunit S10B PSMC6 344245123 1.21 0.045 99
15 Fatty acid-binding protein, epidermal FABP5 1706754 1.21 0.013 66
Cytochrome c oxidase subunit 5B,
mitochondrial
COX5B 117104 1.21 0.013 92
9 Fumarate hydratase FH 66968774 1.20 0.0018 128
13 Esterase D ESD 13937355 1.17 0.0004 49
18 L-lactate dehydrogenase B chain LDHB 6678674 1.14 0.028 489
2 Mitochondrial inner membrane protein iso-
form 3
IMMT 358439528 21.15 0.012 245
8 Eukaryotic translation elongation factor 1
alpha 1
EEF1a1 13278382 21.23 0.03 353
4 Serine/threonine-protein kinase PAK 2 PAK2 351694920 21.25 0.033 87
Dihydropyrimidinase-like 3, isoform
CRA_a (DPYSL3)
CRMP-4 148678069 21.25 0.033 69
1 Serotransferrin precursor TF 20330802 21.29 0.0003 220
7 ATP synthase subunit beta, mitochondrial
precursor
ATP5B 31980648 21.30 0.0082 64
5 Dihydropyrimidinase-like 3, isoform
CRA_a (DPYSL3)
CRMP-4 148678069 21.37 0.021 390
3 Dihydropyrimidinase-related protein 2
(DPYSL2)
CRMP-2 40254595 21.38 0.03 564
14 NADH dehydrogenase [ubiquinone] 1
alpha subcomplex subunit 12
NDUFA12 47117166 21.46 0.041 168
12 Cyclophilin-40 PPID 13385854 21.67 0.038 144
26S protease regulatory subunit S10B PSMC6 344245123 21.67 0.038 117
6 Dihydropyrimidinase-like 4, isoform
CRA_d (DPYSL4)
CRMP-3 148685898 21.69 0.00036 216
T-complex protein 1 subunit zeta CCT6a 6753324 21.69 0.00036 198
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F44(A, B)]. CCT6a was chosen for validation because it
is present in 2 protein spots, spot 16 and 6, which
have the highest ratio of altered expression level
(MMP-32/2 vs. WT), respectively 3.19
(p5 0.00003) and 21.69 (p5 0.00036) (Fig. 2,
Table 1). As spot 6 and 16 show a shift in pI, but also
a small shift in molecular weight (Fig. 1), we
hypothesized that CCT6a might exist in different iso-
forms, as recently described by (Mukherjee et al.,
2010), or/and that CCT6a might be subjected to a
PTM, although the type of PTM remaining elusive
(Li et al., 2006; Xiang et al., 2008; Dun et al., 2011;
Miyata et al., 2014). In addition, CCT6a in spot 6
shows a higher expression in WT samples, while
CCT6a in spot 16 is more abundantly present in
MMP-32/2 cerebella (Fig. 1, lower panels). Western
blotting for CCT6a also revealed a small change in
molecular weight [Fig. 4(A)]. Of note, the smaller
CCT6a form is only visible in MMP-32/2 cerebellar
samples, while CCT6a with the highest molecular
weight is only detectable in WT samples, thereby
confirming the 2D-DIGE data. Semiquantitative anal-
ysis further revealed a significantly reduced expres-
sion of CCT6a in MMP-32/2 cerebella as compared
to the WT samples (1006 6.5% in WT vs. 766 3.0%
in MMP-32/2 (n5 11, p 0.01)) [Fig. 4(B)]. There-
fore, CCT6a seems to be differentially regulated by
MMP-3, possibly by a modification at the transcrip-
tional or/and post-translational level. CCT6a is a
member of the eukaryotic cytosolic chaperonin con-
taining TCP-1 (CCT) complex that mediates folding
of various proteins such as actin and tubulin (Fig. 3;
Abe et al., 2009). To investigate whether CCT6a is
the only subunit that has undergone MMP-3-
dependent modifications during development of the
cerebellum, Western blotting was also performed for
several other CCT subunits, more specifically CCT3,
4, 5, 6b, and 7. Yet, no genotypic differences in
expression level or in molecular weight could be
observed for any of these CCT subunits [Figure 4(C,
D)]. To evaluate whether CCT6a is expressed in the
developing cerebellum, immunohistochemical stain-
ings on the P8 mouse brain were performed and
showed that CCT6a was widely expressed in various
cell types throughout the cerebellar cortex, with a
clear immunopositivity in the Purkinje cell somata,
as revealed by double labeling with Calbindin [Fig.
F66(A–C)].
According to IPA pathway analysis, mitogen-
activated protein kinase 3 (MAPK3) is directly asso-
ciated with CCT6a, but also with several other differ-
entially expressed proteins from the list (Fig. 3). As
such, MAPK3 provides a protein of high interest to
further elucidate the pathway by which MMP-3 inter-
acts with all these proteins, including CCT6a, and
potentially regulates the developmental processes in
the cerebellum. MAPK3 (also named ERK1) consti-
tutes, together with MAPK1 (or ERK2), the extracel-
lular signal regulated kinase (ERK) subfamily of
MAP kinases. As all known stimulants of the ERK1/
2 pathway lead to the activation of both ERK1 and
ERK2, they are mostly referred to as ERK1/2 (Ros-
koski, 2012). An impaired activation of the ERK1/2
signaling pathway, that implies reduced phosphoryla-
tion of the ERKs, is known to cause neurodevelop-
mental and behavioral deficits (Davis and Laroche,
2006; Chirivi et al., 2007; Lefloch et al., 2008;
Samuels et al., 2009; Nuttall and Oteiza, 2012; Puci-
lowska et al., 2012). CCT6a has been identified as a
phosphoprotein and is known to contain ERK binding
sites, but it is not clear yet whether CCT6a is also
phosphorylated by ERK (Xiang et al., 2008; Opper-
mann et al., 2012; Miyata et al., 2014). Western blot-
ting for phosphorylated, and thus activated ERK1
and ERK2, revealed a clearly stronger expression of
pERK2 in comparison to pERK1 in WT cerebellar
samples [Fig. F55(A)], which is in agreement with pre-
viously reported findings in mouse brain (Lefloch
et al., 2008). Importantly, when comparing MMP-32/
2 to WT cerebellar samples with similar protein load-
ing, we could observe significantly decreased expres-
sion levels of both phosphorylated ERK1 and ERK2
kinases in the absence of MMP-3, represented as
average density of the pERK bands related to the
density of the total protein stain (2.4 3 10236 1.4 3
Figure 2 Graph representing the percentage differential
expression of the 18 identified spots with their respective
proteins. The average ratio of protein expression between
MMP-32/2 and WT P8 cerebella reveals that, of the 18 dif-
ferential spots, 8 are upregulated and 10 are downregulated
in MMP-32/2 cerebella as compared to WT extracts. The
most remarkable change in protein levels between the two
conditions is assigned to CCT6a. The order of the bars
matches the order of spots in Table 1.
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1023 in WT vs 0 in MMP-32/2 cerebella for pERK1
(n 6, p< 0.01), and 9.8 3 10236 2.2 3 1023 in
WT vs 2.0 3 10236 1.5 3 1023 in MMP-32/2 cere-
bella for pERK2 (n 7, p< 0.005)) [Fig. 5(B)].
Importantly, the expression of total ERK1/2 was not
affected in the absence of MMP-3 [Fig. 5(C, D)].
Immunohistochemical stainings revealed ERK1/2
expression in all layers of the developing cerebellar
cortex at P8, with a prominent expression in the
molecular layer. Double labeling with Calbindin con-
firms a colocalization in Purkinje cells [Fig. 6(D–F)].
In conclusion, our observations indicate that the
abnormal cerebellar development observed in post-
natal MMP-32/2 pups might, at least partially, be
due to intrinsic (and cell-to-cell) deficits in the MAP
kinase signaling pathway, as shown by the reduced
levels of principally phosphorylated (or activated)
ERK1 and ERK2 in MMP-32/2 cerebella. This
reduced activation of phosphorylated ERK might in
turn lead to a decreased phosphorylation and/or pro-
duction of the molecular chaperone CCT6a, assumed
to be important for a correct cytoskeletal organization
and as such, for the observed aberrant Purkinje cell
dendritogenesis and/or disturbed radial granule cell
migration in MMP-32/2 cerebella.
DISCUSSION
In this study, a 2-D DIGE approach was used to
investigate changes at the proteomic level in the
developing cerebellum of MMP-32/2 mice. The
identification of altered protein levels in postnatal
Figure 3 IPA top network of interactions of the differentially expressed proteins. The IPA tool
created two protein-protein interaction networks. This graph shows a selection of proteins from the
network with the highest score, “cell-to-cell signaling and interaction,” and involves 11 (grey sym-
bols) of the 20 proteins with significantly altered expression levels between MMP-32/2 and WT
cerebella at P8. Notice how MAPK3 (ERK1) is added central to this network by the IPA software.
Solid lines imply direct protein interactions while dotted lines indicate indirect relationships.
(CRMP, collapsin response mediator protein; DPYSL, dihydropyrimidinase-like; Eef1a1, eukaryo-
tic translation elongation factor 1 alpha 1; ESD, esterase D; MAPK3, mitogen-activated protein
kinase 3; CCT6a, chaperonin containing TCP1, subunit 6a (zeta 1); TF, transferrin; PROKR2, pro-
kineticin receptor 2; ACTB, actin, beta; PPID, peptidylprolylisomerase D; FSH, follicle-
stimulating hormone; ATP5B, ATP synthase beta; hspa1l, heat shock protein 1-like; PGK1, phos-
phoglycerate kinase 1).
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MMP-32/2 versus WT cerebella might provide new
valuable insights into MMP-3 signaling pathways
and the mechanisms underlying its contribution to
cerebellar development, or brain development in gen-
eral. Indeed, the cerebellum serves as a highly attrac-
tive model system to study the formation and wiring
of brain circuits during development and how they
impact on brain functioning.
As previously described, the first morphological
and anatomical aberrations in cerebellar development
in MMP-32/2 mice could be observed from P8 on.
More specifically, the cerebellar cortex of MMP-32/
2 mice showed a delayed radial migration of granule
cells and a sustained aberrant Purkinje cell dendrito-
genesis until adulthood (Van Hove et al., 2012). In
the quest towards elucidating how MMP-3 regulates
biological/physiological/cellular functions, these
findings provide further information on MMP-3
related pathways and new molecular targets, supple-
mental to or in confirmation of previously reported
MMP-3 substrates deduced from in vitro studies
(Van Hove et al., 2012). In general, a very limited
amount of data exist concerning the functions and
substrates of MMP-3 in the developing brain, pre-
dominantly because most research on MMP-3 has
focused on its detrimental role in neural and non-
neural tissues (Kim and Hwang, 2011; Van Hove
et al., 2012). It should therefore not be surprising that
none of the 20 proteins revealed by our proteomics
study (Table 1) have been recognized before as being
part of the MMP-3 degradome. However, our study
requires a cautious interpretation as some of these
proteins might be upregulated in the absence of
MMP-3 as a compensation mechanism and therefore
may not, either directly or indirectly, be part of its
signaling pathways.
From the top network classified as “cell-to-cell sig-
naling,” in which most of the differential molecules
Figure 4 Western blotting for T-complex protein 1 subunits. (A) Western blotting shows that
CCT6a (658 kDa) has a lower molecular weight in MMP-32/2 cerebella in comparison to WT cer-
ebella. In addition, the CCT6a that is found in MMP-32/2 cerebella has a lower expression level.
(B) Semiquantitative analysis of the CCT6a optical densities after total protein normalization con-
firms its significantly diminished expression in MMP-32/2 cerebella (n5 11). (C) Representative
Western blots for CCT3, 4, 5, 6b and 7 do not reveal any difference in molecular weight nor expres-
sion level between WT and MMP-32/2 cerebella. (D) Quantification of the normalized CCT subu-
nits reveals equal protein levels between the two genotypes (n5 5). Data are represented as
mean6 SEM; ** p< 0.01.
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were interassociated, we selected the most interesting
cytoskeleton-related protein that could advance our
knowledge about the functional role of MMP-3 in
neuronal migration and dendritogenesis, more specif-
ically CCT6a. Of note, a parallel 2-D DIGE analysis
on cerebella from WT and MMP-32/2 pups at P3
revealed only 5 differently expressed proteins and
CCT6a was not identified as a differentially
expressed protein (data not shown). These findings
strengthen our previous results that also pinpoint an
important role for MMP-3 in cerebellar development
from the second postnatal week on (Van Hove et al.,
2012).
The CCT family consists of 8 distinct subunit
members (1–8 or a–h) of approximately 60 kDa that
constitute the chaperonin containing TCP-1 (CCT)
complex, also known as the TCP-1 ring complex
(TRiC). These 8 subunits with ATPase activity and a
subunit-specific function form a barrel-shaped com-
plex of two stacked eight-membered rings surround-
ing a central cavity that functions as a molecular
chaperone, involved particularly in the correct fold-
ing of actin and tubulin. However, numerous other
proteins have also been identified to interact with
CCT in an ATP-dependent manner (Kubota et al.,
1999; Roobol and Carden, 1999). The identification
of potential CCT substrates has been increasing so
far that approximately 5–10% of all newly synthe-
sized cytoplasmic proteins seem to pass this chaper-
one (Yam et al., 2008). This chaperone is mainly
related to cytoskeletal organization including cell
cycle control, cell migration, growth cone guidance
and developmental morphogenesis. Although it is
clear that the heteromeric CCT oligomer is essential
for the folding activity of actin and tubulin, there is
increasing evidence that the CCT subunits them-
selves may have individual activity (Roobol and Car-
den, 1999; Roobol et al., 1999; Brackley and
Grantham, 2009). Also CCT6a is necessary to ensure
correct folding and oligomerization/polymerization
of native proteins and has, according to in vitro and
in vivo studies, actin and tubulin as major substrates
Figure 5 Expression pattern of phosphorylated and total ERK in WT and MMP-32/2 cerebella.
(A) A representative Western blot for phosphorylated MAPK3/ERK1 and MAPK1/ERK2, shows
reduced bands at respectively 44 and 42 kDa in MMP-32/2 samples as compared to WT cerebella.
This blot also reveals that especially pERK2 is abundantly expressed in postnatal cerebella of WT
mice. Coomassie blue staining served as a loading control. (B) Semiquantitative analysis confirmed
that both pERK1 and pERK2 are remarkably decreased or even undetectable in MMP-32/2 cere-
bella as compared to WT samples, when analysed at equal protein concentration. (C) Representa-
tive protein bands corresponding to total ERK1 and ERK2, as well as the loading control, are
shown for the same WT and MMP-32/2 P8 cerebellar samples. (D) Bar graph representing semi-
quantitative Western blot analyses confirmed equal amounts of total ERK levels and a similar ratio
of total ERK1 and ERK2 expression between WT and MMP-32/2 cerebella. Data are represented
as mean6SEM; n 6; **p< 0.01, ***p< 0.005.
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(Brackley and Grantham, 2009). In addition, CCT6a
was found to be expressed at higher levels in the
mouse forebrain at P10, in comparison to the adoles-
cent and adult stage, as observed via 2-D DIGE
(Laeremans et al., 2013). Moreover, immunohisto-
chemical stainings on P8 mouse brain revealed
CCT6a expression throughout the cerebellar cortex.
As seen in the proteomics study, MMP-3 deficiency
clearly affects CCT6a expression and might thus be a
modulator of CCT6a transcription and/or post-
translational modification during development.
Although there are only very few quantitative studies
describing PTM changes during postnatal CNS devel-
opment, PTMs such as phosphorylation, acetylation
and glycosylation seem to have important functions
in controlling brain morphogenesis. Furthermore,
recent evidence has demonstrated that specifically
cytoskeletal proteins, involved in neuronal process
extension and maintenance, are the most heavily
modified and most frequently regulated at PTM level
during mouse brain development. Interestingly,
cytoskeletal proteins seem primarily regulated by
phosphorylation (Goswami et al., 2012; Edwards






Figure 6 CCT6a and ERK1/2 expression pattern in the cerebellar cortex of WT P8 pups. (A)
Immunohistochemical stainings for CCT6a reveal a uniformly stained pattern throughout the whole
cerebellar cortex of P8 mouse pups, indicating its broad cellular expression. (B) Double labeling
with the Purkinje cell marker Calbindin discloses CCT6a expression in the Purkinje cell somata
and dendrites. (C) No labeling is seen in negative control sections (without primary antibodies for
CCT6a and Calbindin), (D) ERK1/2 expression in the P8 cerebellar cortex is observed in all cere-
bellar layers, but especially prominent in the molecular layer, which contains the growing Purkinje
cell dendrites, and migrating granule cells and inhibitory interneurons. (E) Double staining with
Calbindin confirms ERK1/2 immunostaining in the Purkinje cells, especially in the dendrites. (F)
Negative control sections (without primary antibodies for ERK1/2 and Calbindin) do not show any
staining. (EGL, external granular layer; ML, molecular layer; PCL, Purkinje cell layer; IGL, inter-
nal granular layer). Scale bar: 100 mm
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to be phosphorylated by the ribosomal S6 kinases,
RSK and S6K upon activation by the MAP kinase
pathway and in response to for example, growth fac-
tors (Abe et al., 2009). CCT6a has also been identi-
fied as a phosphoprotein in adult rat ventricular
myocytes subjected to diazoxide preconditioning (Li
et al., 2006). Recently, a phospho-proteomic
approach unveiled in vivo phosphorylation sites on
CCT subunits, including CCT6a, more specifically,
on serine and threonine residues (Miyata et al.,
2014). CCT6a has also been described to possess
phosphorylation sites for MAPK/ERK, yet it is still
unclear whether PTMs such as phosphorylation are
necessary for this subunit to be activated (Xiang
et al., 2008; Roskoski, 2012). Importantly, stimula-
tion of PC12 cells with epidermal growth factor
(EGF) or nerve growth factor (NGF) identified
CCT6a as a specific component of endogenous
ERK1/2 signaling complexes (von Kriegsheim et al.,
2009). Although not much is known about the exact
functions of the different subunits as well as the
composition-related functions of this chaperone, our
findings provide valuable insight into the individual
function(s) of CCT6a and its expression in the devel-
oping brain.
Since phosphorylation of the CCT complex may
affect its function, we focused on a central phos-
phorylating enzyme in the IPA top network,
MAPK3 or ERK1, related to several of the other
differential proteins identified from our 2-D DIGE
study by this software, more specifically eukaryotic
translation elongation factor 1 alpha 1 (Eef1a1),
collapsin response mediator proteins (CRMPs),
phosphoglycerate kinase 1 (PGK1), ATP synthase
b (ATP5B) and CCT6a. MAPK3/ERK1 and
MAPK1/ERK2 belong to the classic ERKs, which
are part of an important signaling transduction cas-
cade, the Ras/Raf/MEK/ERK pathway, which is a
key pathway in transducing extracellular signals at
the cell membrane into a cascade of kinase activa-
tions that ultimately phosphorylate a wide range of
substrates in the nucleus, cytosol, at membranes
and in cytoskeletal compartments. This pathway is
involved in many basic cellular processes such as
proliferation, differentiation, survival and apoptosis.
Importantly, the observed incidence of phospho-
regulation in cytoskeletal proteins during brain
development has been, amongst others, attributed
to ERK activity. In the CNS, MAPK is assumed
to be abundantly present in most or all neurons
and its signaling cascade has been associated with
brain development, for example, cell division and
differentiation, synaptic plasticity, learning and
memory, emotional behaviour, etc. (Sweatt, 2001;
Tonini et al., 2006; Chirivi et al., 2007; Zhong
et al., 2007; Galabova-Kovacs et al., 2008; Wefers
et al., 2012; Edwards et al., 2014). Conversely,
disturbances in the ERK signaling pathway have
been associated with a diverse range of neurodeve-
lopmental disorders (Weeber and Sweatt, 2002;
Bentires-Alj et al., 2006; Samuels et al., 2008).
For the P8 developing cerebellar cortex, we here
revealed ERK1/2 expression in all layers of the
cerebellum, especially in the molecular layer,
which contains at this specific time point the
growing Purkinje cell dendrites and migrating
granule cells and inhibitory interneurons (stellate
and basket cells). The observed reduction in phos-
phorylated ERK1/2, but not in total ERK1/2 levels,
in MMP-32/2 cerebellum strongly suggests that
the abnormal cerebellar development in MMP-32/2
mice is due to intrinsic deficits in this MAPK cas-
cade pathway. Of note, it has been reported that
the MAPK pathway regulates dendritic length, but
not soma size, of hippocampal neurons in culture,
and that MAPK activation is required for neurite
outgrowth of cerebellar neurons (Schmid et al.,
2000; Jaworski et al., 2005; Kumar et al., 2005).
In general, an increasing amount of studies points
towards the importance of activated/phosphorylated
MAPK in supporting neurite outgrowth (Hobson
et al., 2006; Meng et al., 2007; Obara et al., 2009;
Washio et al., 2009; Wang et al., 2011). This
observation perfectly fits our previous findings on
Purkinje cell morphology in MMP-32/2 mice,
where we also noticed a reduced dendritic tree
size, but no changes in soma size, in postnatal and
adult MMP-32/2 cerebella (Van Hove et al.,
2012). Of note, also a clear reduction in apical
dendritic length of pyramidal neurons has recently
been demonstrated in the visual cortex of adult
MMP-32/2 mice (Aerts et al., 2014).
The extracellular factor, which is directly cleaved
or activated by MMP-3 and subsequently initiates the
MAPK pathway or rather activation (phosphoryla-
tion) of ERK1/2, remains elusive [Fig. F77(A)]. Growth
factors and mitogens are among the strongest activa-
tors of ERK1/2 [Fig. 7(A)]. Yet, also electrical activ-
ity, receptor tyrosine kinases, G-protein-coupled
receptors and integrins have been described to induce
MAPK phosphorylation (Morrison, 2012). One of the
upstream mediators of this cascade and known sub-
strate of MMP-3 is pro-NGF, which is supposed to
mediate axon outgrowth and cell survival via this
pathway (Egea et al., 2000; Zhong et al., 2007). A
functional interaction between MMPs and the MAPK
pathway has barely been described. Most often,
MMP expression can be influenced by
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phosphorylation of transcription factors for MMPs by
ERK1/2 (Kim and Lee, 2005; Mahmoodzadeh et al.,
2010). However, it has been hypothesized that the G
protein receptor kinase (GRK)/b-arrestin mediated
ERK activation is mediated by shedding of HB-EGF
by MMPs (Dorn, 2009) [Fig. 7(A)].
With regard to the top biological functions as
proposed by IPA, cellular assembly and organiza-
tion and neuritogenesis can clearly be related to the
previously observed findings in MMP-32/2 mice.
Moreover, semaphorin signaling in neurons, which
is important in multiple developmental CNS proc-
esses, such as neuritogenesis and guidance, was
demonstrated as being the most significant top
canonical pathway. From the five known vertebrate
CRMPs, CRMP-2-4 were differentially expressed
based on the 2-D DIGE. Importantly, CRMP family
members have been recognized as being down-
stream targets of semaphorin 3A (Schmidt and
Strittmatter, 2007) and semaphorins are known reg-
ulators of MMP-3 expression/activity (Gonthier
et al., 2007) [Fig. 7(B)]. In addition, CRMPs have
been repeatedly reported for their contribution to
brain development, and suggested to regulate cellu-
lar organization, growth cone dynamics, neurite
outgrowth and dendritic patterning (Wang and
Strittmatter, 1996; Arimura et al., 2005; Yoshimura
et al., 2005; Yamashita et al., 2011; Tsutiya and
Ohtani-Kaneko, 2012; Tan et al., 2013; Ji et al.,
2014; Verslegers et al., 2014). CRMPs in turn bind
actin, which is another differentially regulated pro-
tein identified in this study, and have been
Figure 7 Schematic overview of the possible MMP-3 related molecular pathways in cerebellar
development. (A) Extracellular cleavage, and thus activation, of growth factors, such as pro-NGF
by MMP-3, can activate the MAP kinase signalling pathway. After binding of the growth factor to
its corresponding receptor, Ras is activated and subsequently induces a kinase cascade that ulti-
mately results in phosphorylation/activation of ERK. Subsequent phosphorylation of CCT6a, either
as a component of the hetero-oligomeric chaperonin particle, as free subunits or as smaller oligom-
ers, by ERK might result in folding of for example, actin and tubulin, both major and essential
cytoskeletal cellular components. (B) Semaphorins are known regulators of MMP-3 expression and
activity. As CRMPs are increasingly being recognized as members of the MMP degradome, MMP-
3 activation might subsequently influence CRMP activities, either directly via cleavage, or indi-
rectly via modulating CRMP phosphorylation. CRMPs are also identified substrates of ERK1/2 and
known to bind for example, actin and tubulin, thereby modulating cytoskeletal dynamics. Although
hypothetical, these molecular pathways might underlie the contribution of MMP-3 to developmen-
tal processes in the brain such as neurite outgrowth, neuronal migration and dendritic arborization.
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described to modulate actin bundling, thereby influ-
encing growth cone dynamics (Arimura et al.,
2005; Rosslenbroich et al., 2005; Khazaei et al.,
2014) [Fig. 7(B)]. In addition, actin is also a direct
client of CCT and next to growth cone steering,
also importantly implicated in synaptogenesis and
neurite branching (Llorca et al., 1999; Leung et al.,
2006; Chia et al., 2014) (Fig. 7). From the list of
differential spots, other proteins also support the
previously observed phenotype in MMP-32/2 cere-
bella. More specifically, epidermal fatty acid bind-
ing protein (eFABP) (Liu et al., 2008; Knoferle
et al., 2010; Liu et al., 2010), glyoxalase I (Kuhla
et al., 2006), Eef1a1 (Hashimoto and Ishima, 2011),
cyclophilin (Yuan et al., 1997), serine/threonine
protein kinase (PAK2) (Shin et al., 2002; Shin
et al., 2009), and so forth, have been reported to
regulate neurite outgrowth/retraction, and/or neuro-
nal migration. Notably, they are often correlated to
MAPK signaling. A summarizing scheme about the
possible molecular mechanisms underlying MMP-3-
regulated functions during brain development,
including neurite outgrowth, dendritogenesis and
neuronal migration, is proposed in Figure 7.
Overall, it seems plausible to conclude from our
findings that MMP-3 modulates, either directly or
indirectly, the intracellular MAP kinase signaling
pathway and as such, influences a molecular chaper-
one that regulates cytoskeletal components important
for neurite outgrowth, neuronal migration and dendri-
tic arborization.
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